Reme-D

New York, United States

Reme-D develops diagnostic tests for underserved markets

Apr 2026

Seed

Top Investors

Wharton School of the University of PennsylvaniaGlobal Innovation FundMohammed Bin Rashid Innovation Fund (MBRIF)A15Oman Technology Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Reme-D

Who are Reme-D's investors?

Reme-D's investors include Wharton School of the University of Pennsylvania, Global Innovation Fund, Mohammed Bin Rashid Innovation Fund (MBRIF), A15, Oman Technology Fund.

Where is Reme-D headquartered?

Reme-D is headquartered in New York, United States.

What does Reme-D do?

Reme-D develops diagnostic tests for underserved markets

What stage is Reme-D at?

Reme-D is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 2, 2026.

MLA

"Reme-D — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/reme-d. Accessed June 17, 2026.

APA

VCBacked. (2026). Reme-D — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/reme-d

Wikipedia (cite web)

{{cite web |title=Reme-D — Funding & Investors |url=https://www.vcbacked.co/company/reme-d |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 2, 2026.

Similar Companies in Biotechnology